Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: A meta-analysis of randomised controlled trials

The Lancet Diabetes and Endocrinology

Volumn 1, Issue 4, 2013, Pages 317-328

  Verma, Subodh ^a,b,d   Farkouh, Michael E ^b,c,d   Yanagawa, Bobby ^d   Fitchett, David H ^a,b,d   Ahsan, Muhammad R ^a   Ruel, Marc ^g   Sud, Sachin ^d,h   Gupta, Milan ^a,b,d,i   Singh, Shantanu ^f   Gupta, Nandini ^a,g   Cheema, Asim N ^a,b,d   Leiter, Lawrence A ^a,b,d,e   Fedak, Paul W M ^j   Teoh, Hwee ^a,b   Latter, David A ^a,b,d   Fuster, Valentin ^k,l   Friedrich, Jan O ^a,b,d,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f PRAMUKHSWAMI MEDICAL COLLEGE   (India)

^g UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^h CREDIT VALLEY HOSPITAL   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

^j UNIVERSITY OF CALGARY   (Canada)

^k MOUNT SINAI MEDICAL CENTER   (United States)

^l CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; BARE METAL STENT; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT RESPONSE; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY DISEASE; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME;

CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84887621557     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70089-5     Document Type: Article

References (36)

1. Beckman JA, Paneni F, Cosentino F, Creager MA Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 2013, published online April 26. 10.1093/eurheartj/eht142.
2. Barkoudah E, Skali H, Uno H, Solomon SD, Pfeffer MA Mortality rates in trials of subjects with type 2 diabetes. J Am Heart Assoc 2012, 1:8-15.
3. Magnuson EA, Farkouh ME, Fuster V, et al. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation 2013, 127:820-831.
4. Bates ER Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus. Heart 2013, published online March 8. 10.1136/heartjnl-2013-303820.
5. Frye RL, August P, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515. BARI 2D Study Group.
6. Brooks MM, Chaitman BR, Nesto RW, et al. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation 2012, 126:2115-2124.
7. Daemen J, Boersma E, Flather M, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008, 118:1146-1154.
8. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012, 367:2375-2384.
9. Kappetein AP, Head SJ, Morice MC, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 2013, 43:1006-1013.
10. Hall R. CARDia: coronary artery revascularisation in diabetes trial (5-year follow-up data). European Society of Cardiology Congress; Munich, Germany; 2012; Aug 25-29, 2012.
11. Kamalesh M, Sharp TG, Tang XC, et al. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol 2013, 61:808-816.
12. DerSimonian R, Laird N Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
14. Egger M, Davey Smith G, Schneider M, Minder C Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
15. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295:676-680.
16. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 2010, 55:432-440.
17. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001, 104:533-538.
18. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001, 344:1117-1124.
19. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 2005, 46:575-581.
20. Rodriguez A, Bernardi V, Navia J, et al. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 2001, 37:51-58.
21. Rodriguez A, Rodriguez Alemparte M, Baldi J, et al. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study. Heart 2003, 89:184-188.
22. Rodriguez AE, Baldi J, Fernandez Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005, 46:582-588.
23. Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008, 118:381-388.
24. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002, 360:965-970. SoS Investigators.
25. Weintraub WS, Mahoney EM, Zhang Z, et al. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial. Heart 2004, 90:782-788.
26. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007, 115:1082-1089.
27. Hueb W, Soares PR, Gersh BJ, et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004, 43:1743-1751.
28. Soares PR, Hueb WA, Lemos PA, et al. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Circulation 2006, 114:I420-I424.
29. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011, 32:2125-2134.
30. Mack MJ, Banning AP, Serruys PW, et al. Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg 2011, 92:2140-2146.
31. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010, 55:1067-1075.
32. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009, 373:1190-1197.
33. Taggart DP CABG or stents in coronary artery disease: end of the debate?. Lancet 2013, 381:605-607.
34. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 58:e123-e210.
35. Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012, 33:2451-2496. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, European Association for Cardio-Thoracic SurgeryEuropean Association for Cardio-Thoracic Surgery.
36. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.